View in EDS

The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.

Saved in:
Bibliographic Details
Title: The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.
Authors: Schram AM; Memorial Sloan Kettering Cancer Center, New York, New York., Naqash AR; OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Sarah Cannon Research Institute, Nashville, Tennessee., Haura EB; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Riess JW; UC Davis Comprehensive Cancer Center, Sacramento, California., Ulahannan SV; OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Sarah Cannon Research Institute, Nashville, Tennessee., Ou SI; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California., Munster PN; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California., Cheng ML; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California., Gustafson WC; Revolution Medicines, Redwood City, California., Bitman B; Revolution Medicines, Redwood City, California., Friedman R; Revolution Medicines, Redwood City, California., Penn R; Revolution Medicines, Redwood City, California., Kar S; Revolution Medicines, Redwood City, California., Seshadri V; Revolution Medicines, Redwood City, California., Wang Z; Revolution Medicines, Redwood City, California., Tao L; Revolution Medicines, Redwood City, California., Yang YC; Revolution Medicines, Redwood City, California., Singh M; Revolution Medicines, Redwood City, California., Burris HA; Sarah Cannon Research Institute, Nashville, Tennessee., Meyerowitz JG; Revolution Medicines, Redwood City, California.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Dec 01; Vol. 31 (23), pp. 4933-4943.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41056387
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schram+AM%22">Schram AM</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Naqash+AR%22">Naqash AR</searchLink>; OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Sarah Cannon Research Institute, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Haura+EB%22">Haura EB</searchLink>; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Riess+JW%22">Riess JW</searchLink>; UC Davis Comprehensive Cancer Center, Sacramento, California.<br /><searchLink fieldCode="AU" term="%22Ulahannan+SV%22">Ulahannan SV</searchLink>; OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Sarah Cannon Research Institute, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Ou+SI%22">Ou SI</searchLink>; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California.<br /><searchLink fieldCode="AU" term="%22Munster+PN%22">Munster PN</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Cheng+ML%22">Cheng ML</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Gustafson+WC%22">Gustafson WC</searchLink>; Revolution Medicines, Redwood City, California.<br /><searchLink fieldCode="AU" term="%22Bitman+B%22">Bitman B</searchLink>; Revolution Medicines, Redwood City, California.<br /><searchLink fieldCode="AU" term="%22Friedman+R%22">Friedman R</searchLink>; Revolution Medicines, Redwood City, California.<br /><searchLink fieldCode="AU" term="%22Penn+R%22">Penn R</searchLink>; Revolution Medicines, Redwood City, California.<br /><searchLink fieldCode="AU" term="%22Kar+S%22">Kar S</searchLink>; Revolution Medicines, Redwood City, California.<br /><searchLink fieldCode="AU" term="%22Seshadri+V%22">Seshadri V</searchLink>; Revolution Medicines, Redwood City, California.<br /><searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; Revolution Medicines, Redwood City, California.<br /><searchLink fieldCode="AU" term="%22Tao+L%22">Tao L</searchLink>; Revolution Medicines, Redwood City, California.<br /><searchLink fieldCode="AU" term="%22Yang+YC%22">Yang YC</searchLink>; Revolution Medicines, Redwood City, California.<br /><searchLink fieldCode="AU" term="%22Singh+M%22">Singh M</searchLink>; Revolution Medicines, Redwood City, California.<br /><searchLink fieldCode="AU" term="%22Burris+HA%22">Burris HA</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Meyerowitz+JG%22">Meyerowitz JG</searchLink>; Revolution Medicines, Redwood City, California.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2025 Dec 01; Vol. 31 (23), pp. 4933-4943.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41056387
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-25-2112
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4933
    Titles:
      – TitleFull: The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schram AM
      – PersonEntity:
          Name:
            NameFull: Naqash AR
      – PersonEntity:
          Name:
            NameFull: Haura EB
      – PersonEntity:
          Name:
            NameFull: Riess JW
      – PersonEntity:
          Name:
            NameFull: Ulahannan SV
      – PersonEntity:
          Name:
            NameFull: Ou SI
      – PersonEntity:
          Name:
            NameFull: Munster PN
      – PersonEntity:
          Name:
            NameFull: Cheng ML
      – PersonEntity:
          Name:
            NameFull: Gustafson WC
      – PersonEntity:
          Name:
            NameFull: Bitman B
      – PersonEntity:
          Name:
            NameFull: Friedman R
      – PersonEntity:
          Name:
            NameFull: Penn R
      – PersonEntity:
          Name:
            NameFull: Kar S
      – PersonEntity:
          Name:
            NameFull: Seshadri V
      – PersonEntity:
          Name:
            NameFull: Wang Z
      – PersonEntity:
          Name:
            NameFull: Tao L
      – PersonEntity:
          Name:
            NameFull: Yang YC
      – PersonEntity:
          Name:
            NameFull: Singh M
      – PersonEntity:
          Name:
            NameFull: Burris HA
      – PersonEntity:
          Name:
            NameFull: Meyerowitz JG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 23
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1